MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
What the film says
This trial is for adults with stage four or recurrent non-small cell lung cancer who have not had treatment for advanced disease.
The idea: give two immunotherapy antibodies, nivolumab and ipilimumab, by vein, and add N-803, a shot under the skin. N-803 is a form of interleukin 15, a signal that helps immune cells grow and stay active. The hope is that it boosts the other two drugs.
The study looks at safety and how well it works.
This phase 1 and 2 study plans 26 patients. At Washington University School of Medicine in St. Louis, Giordano Cittolin Santos leads it.
Public record; not medical advice.
Sources behind this film
Adults; stage IV or recurrent NSCLC; first line; Nivolumab + ipilimumab IV; N-803 subcutaneous; IL-15; augment the two drugs; Phase 1/2; 26; WashU; Giordano Cittolin Santos
The drug
Nogapendekin alfa inbakicept will be given subcutaneously at the assigned dose level.
Ipilimumab will be given intravenously at a dose of 1mg/kg.
The study
This is a single center, phase Ib/II study combining an anti-PD-1 antibody and an anti-CTLA-4 antibody with IL-15. It is testing the hypothesis that the addition of nogapendekin alfa inbakicept to nivolumab and ipilimumab will augment the clinical activity of those two drugs.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.